BMY vs EME · P/E 17, rev $24.46B vs P/E 24, rev $9.78B
Bristol-Myers Squibb Company (BMY) versus EMCOR Group Inc (EME) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
EMCOR Group Inc (EME) is a engineering & construction company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EME revenue for 2026-06-30 was $9.78B. Net income was $709.2M. EME currently screens at market cap $24.23B and trailing P/E 24.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EME currently screens at market cap $24.23B and trailing P/E 24.0.
Not investment advice. Open the BMY and EME stock pages for the full models.
Not investment advice.